Why didn't MEIP run a controlled trial comparing pracinostat+azacitidine to placebo+azacitidine so we could truly gauge how much pracinostat itself is contributing to this data?
In this patient population, it is well-understood how azacitidine performs.
The kind of trial you're asking for in being run by MEIP in MDS.